Effect of different doses of FA-SnO₂ NPs (50 mg/kg for group B, 100 mg/kg for group C and 200 mg/kg for group D) on biochemical profiling of the tested male Wistar rats... حسب Demiana H. Hanna (11512956)

Effect of different doses of FA-SnO₂ NPs (50 mg/kg for group B, 100 mg/kg for group C and 200 mg/kg for group D) on hematological parameters of the tested male Wistar ra... حسب Demiana H. Hanna (11512956)

Effects of GM-CSF on the DMN-induced inhibition of PPAR-γ expression. حسب Mrigendra Bir Karmacharya (13607415)

الموضوعات:

Effects of GM-CSF on DMN-induced TGF-β1 expression. حسب Mrigendra Bir Karmacharya (13607415)

الموضوعات:

Western blot analysis of collagen type I, α-SMA, and TGF-β1 in liver. حسب Mrigendra Bir Karmacharya (13607415)

الموضوعات:

Effects of GM-CSF on DMN-induced hepatotoxicity. حسب Mrigendra Bir Karmacharya (13607415)

الموضوعات:

The effects of GM-CSF on DMN-induced histopathological changes. حسب Mrigendra Bir Karmacharya (13607415)

الموضوعات:

Serum samples and 50% NAI values. Serum samples taken from CEIRS study. حسب Harrison Powell (9040128)

Test characteristics for identifying stenosis ≥ 50% in any limb from aorta till popliteal artery in the overall population (<i>n = 126 limbs</i>). حسب O. Stivalet (6890189)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"

Decrease of the DXR-induced genotoxicity and nongenotoxic effects of Theobroma cacao revealed by micronucleus assay حسب M. F. G. Boriollo (4894975)

Alternative bounded and monotonically decreasing functions do not accurately fit the bias in the naïve SI. حسب Liron Sheintuch (12078310)

Mean (±95%CI) Rating of perceived exertion measured using a numeric scale (1–10) for the Nordic hamstring exercise, Sprint and control groups. حسب Nicholas J. Ripley (14709756)

الموضوعات:

Decreasing neural activity in MBONs that suppress PER when activated has modest effects. حسب Justine Chia (5459294)

Loss of Prox1a decreases PR production at 120 hours post-ablation. حسب Kellie Veen (17343374)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

"…(B) For each group, the median Ki-67 immunostained parathyroid sample closest to the group mean is shown. Each dot represents one sample. Scale bars measures 50μm.…"

Overexpression of mC4 decreased membrane capacitance without altering overall excitability. حسب Ashley L. Comer (8299128)

Total tau levels are significantly decreased in the healthy older brains compared to the younger brains. حسب Shreyasi Chatterjee (3531506)

Exposure to low CO₂ levels decreases ER cholesterol levels. حسب Nityanand Bolshette (17396845)

"…<b>(F)</b> qPCR analysis for cholesterogenic genes from NIH3T3 cells exposed to cholesterol (50 μm) or 25-hydroxycholesterol (10 μm) under 5% or 1% CO₂ for 4 h (mean ± SE, <i>n</i> = 3 biological replicates per condition, ***<i>P</i> < 0.001, nonsignificant (ns), two-way ANOVA with Bonferroni’s multiple comparisons test). …"